Department of Medicine, Division of Rheumatology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.
Arthritis Research Canada, 5591 No. 3 Road, Richmond, BC, V6X 2C7, Canada.
BMC Health Serv Res. 2019 Aug 14;19(1):572. doi: 10.1186/s12913-019-4379-4.
The study evaluates Performance Measures (PMs) for Juvenile Idiopathic Arthritis (JIA): The percentage of patients with new onset JIA with at least one visit to a pediatric rheumatologist in the first year of diagnosis (PM1); and the percentage of patients with JIA under rheumatology care seen in follow-up at least once per year (PM2).
Validated JIA case ascertainment algorithms were used to identify cases from provincial health administrative databases in Manitoba, Canada in patients < 16 years between 01/04/2005 and 31/03/2015. PM1: Using a 3-year washout period, the percentage of incident JIA patients with ≥1 visit to a pediatric rheumatologist in the first year was calculated. For each fiscal year, the proportion of patients expected to be seen in follow-up who had a visit were calculated (PM2). The proportion of patients with gaps in care of > 12 and > 14 months between consecutive visits were also calculated.
One hundred ninety-four incident JIA cases were diagnosed between 01/04/2008 and 03/31/2015. The median age at diagnosis was 9.1 years and 71% were female. PM1: Across the years, 51-81% of JIA cases saw a pediatric rheumatologist within 1 year. PM2: Between 58 and 78% of patients were seen in yearly follow-up. Gaps > 12, and > 14, months were observed once during follow-up in 52, and 34%, of cases, and ≥ twice in 11, and 5%, respectively.
Suboptimal access to pediatric rheumatologist care was observed which could lead to diagnostic and treatment delays and lack of consistent follow-up, potentially negatively impacting patient outcomes.
本研究评估了青少年特发性关节炎(JIA)的绩效指标(PMs):新诊断 JIA 患者中,第一年至少有一次儿科风湿病学家就诊的比例(PM1);以及接受风湿病学治疗的 JIA 患者在随访中至少每年就诊一次的比例(PM2)。
使用验证后的 JIA 病例确定算法,从加拿大马尼托巴省的省级卫生行政数据库中确定 2005 年 4 月 1 日至 2015 年 3 月 31 日期间 16 岁以下的患者病例。PM1:采用 3 年洗脱期,计算第一年至少有一次儿科风湿病学家就诊的新诊断 JIA 患者比例。对于每个财政年度,计算预计在随访中就诊的患者比例(PM2)。还计算了连续就诊之间存在超过 12 个月和超过 14 个月的护理空白的患者比例。
2008 年 4 月 1 日至 2015 年 3 月 31 日期间共诊断出 194 例新发病例 JIA。诊断时的中位年龄为 9.1 岁,71%为女性。PM1:在这几年中,51-81%的 JIA 病例在 1 年内接受了儿科风湿病学家的治疗。PM2:在每年的随访中,有 58-78%的患者接受了治疗。在随访期间,52%和 34%的患者各有一次就诊间隔超过 12 个月和超过 14 个月,11%和 5%的患者各有两次或两次以上就诊间隔超过 12 个月和超过 14 个月。
观察到儿科风湿病学家治疗的机会不足,这可能导致诊断和治疗延迟,以及缺乏持续的随访,从而对患者的结果产生负面影响。